Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA): 8 sponsored US clinical trials, 3 recruiting.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) sponsors 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Familial Adenomatous Polyposis, with 2 trials.
Upper-quartile sponsor footprint
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
NCT04678011
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
NCT04677998
Distribution of Lymph Node Metastases in Esophageal Carcinoma
NCT03222895
A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing
NCT03495297
Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
NCT04485234
Prevention of Phantom Limb Pain After Transtibial Amputation
NCT01626755
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
NCT01828697
PROVHILO:Protective Ventilation During General Anesthesia for Open Abdominal Surgery
NCT01441791
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Where Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) enrollment is open (later-stage tilt)
3 recruiting of 8 indexed (38% open); 3 completed (38%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Familial Adenomatous Polyposis (2 trials), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA): open-pipeline peers nationwide
Peers matched on 8 registered trials and 38% open enrollment, not the therapeutic-area sidebar.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Aciex Therapeutics · 8 trials · 0% recruiting
Sponsors near 38% open enrollment (± trial volume)
- American Thrombosis and Hemostasis Network · 38% recruiting · 8 trials
- AskBio · 38% recruiting · 8 trials
- Athletic Greens International · 38% recruiting · 8 trials
- Banner Health · 38% recruiting · 8 trials
Related
What to do with this Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) page
8 registered trials is a research-attention snapshot, not an endorsement of Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) or any single study.
- 3 of Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Familial Adenomatous Polyposis is the condition Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Familial Adenomatous Polyposis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.